using ancient protein kinases unravel modern cancer drugs mechanism 
macromolecular function rooted energy landscapes sequence determines single structure ensemble conformations hence evolution modifies proteins function altering energy landscape recreate evolutionary pathway two modern human oncogenes src abl reconstructing common ancestors evolutionary reconstruction combined x-ray structures common ancestor pre-steady-state kinetics reveals detailed atomistic mechanism selectivity successful cancer drug gleevec gleevec affinity gained evolutionary trajectory toward abl lost toward src primarily shifting induced-fit equilibrium also disrupted clinical t315i resistance mutation work reveals mechanism gleevec specificity offering insights energy landscapes evolve 
